BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 8386280)

  • 1. Mutation of the C/EBP binding sites in the Rous sarcoma virus long terminal repeat and gag enhancers.
    Ryden TA; de Mars M; Beemon K
    J Virol; 1993 May; 67(5):2862-70. PubMed ID: 8386280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of avian leukosis virus long terminal repeat-enhanced transcription by C/EBP-Rel interactions.
    Bowers WJ; Baglia LA; Ruddel A
    J Virol; 1996 May; 70(5):3051-9. PubMed ID: 8627783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The VBP and a1/EBP leucine zipper factors bind overlapping subsets of avian retroviral long terminal repeat CCAAT/enhancer elements.
    Smith CD; Baglia LA; Curristin SM; Ruddell A
    J Virol; 1994 Oct; 68(10):6232-42. PubMed ID: 8083963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Avian retroviral long terminal repeats bind CCAAT/enhancer-binding protein.
    Ryden TA; Beemon K
    Mol Cell Biol; 1989 Mar; 9(3):1155-64. PubMed ID: 2725492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CArG, CCAAT, and CCAAT-like protein binding sites in avian retrovirus long terminal repeat enhancers.
    Zachow KR; Conklin KF
    J Virol; 1992 Apr; 66(4):1959-70. PubMed ID: 1312613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of EFIV, a stable factor present in many avian cell types that transactivates sequences in the 5' portion of the Rous sarcoma virus long terminal repeat enhancer.
    Houtz EK; Conklin KF
    J Virol; 1996 Jan; 70(1):393-401. PubMed ID: 8523553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning of Rous sarcoma virus enhancer factor genes. I. Evidence that RSV-EF-I is related to Y-box (inverted CCAAT) binding proteins and binds to multiple motifs in the RSV enhancer.
    Kandala JC; Guntaka RV
    Virology; 1994 Feb; 198(2):514-23. PubMed ID: 8291233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a third protein factor which binds to the Rous sarcoma virus LTR enhancer: possible homology with the serum response factor.
    Boulden A; Sealy L
    Virology; 1990 Jan; 174(1):204-16. PubMed ID: 2152992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of nuclear proteins that bind the EFII enhancer sequence in the Rous sarcoma virus long terminal repeat.
    Sears RC; Sealy L
    J Virol; 1992 Nov; 66(11):6338-52. PubMed ID: 1328670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple forms of C/EBP beta bind the EFII enhancer sequence in the Rous sarcoma virus long terminal repeat.
    Sears RC; Sealy L
    Mol Cell Biol; 1994 Jul; 14(7):4855-71. PubMed ID: 8007984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning of Rous sarcoma virus enhancer factor genes. II. RSV-EF-II, abundantly expressed in fibroblasts and muscle tissue, binds to an octamer sequence, 5'-GTACCACC-3', in the noncoding strand of RSV enhancer.
    Cleavinger PJ; Shin BA; Kandala JC; Nambiar A; Swamynathan SK; Guntaka RV
    Virology; 1996 Aug; 222(1):133-43. PubMed ID: 8806494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. a1/EBP: a leucine zipper protein that binds CCAAT/enhancer elements in the avian leukosis virus long terminal repeat enhancer.
    Bowers WJ; Ruddell A
    J Virol; 1992 Nov; 66(11):6578-86. PubMed ID: 1328681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional and defective components of avian endogenous virus long terminal repeat enhancer sequences.
    Habel DE; Dohrer KL; Conklin KF
    J Virol; 1993 Mar; 67(3):1545-54. PubMed ID: 8382309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of Rous sarcoma virus long terminal repeat promoter activity by a HeLa cell basic protein.
    Yeh CH; Shatkin AJ
    Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11002-6. PubMed ID: 7971997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The C/EBP site in the feline immunodeficiency virus (FIV) long terminal repeat (LTR) is necessary for its efficient replication and is also involved in the inhibition of FIV LTR-directed gene expression by pseudorabies virus ICP4.
    Kawaguchi Y; Tomonaga K; Maeda K; Ono M; Miyazawa T; Kohmoto M; Tohya Y; Mikami T
    Virology; 1995 Apr; 208(2):492-9. PubMed ID: 7747422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional activity of the Rous sarcoma virus long terminal repeat correlates with binding of a factor to an upstream CCAAT box in vitro.
    Greuel BT; Sealy L; Majors JE
    Virology; 1990 Jul; 177(1):33-43. PubMed ID: 2162108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host- and tissue-specific factors that interact with the enhancer sequences of Rous sarcoma virus LTR.
    Guntaka RV; Kandala JC; Shin BA; Nambiar A; Svoboda J; Cleavinger P
    Folia Biol (Praha); 1994; 40(5):237-47. PubMed ID: 7895854
    [No Abstract]   [Full Text] [Related]  

  • 18. Ig/EBP-1: a ubiquitously expressed immunoglobulin enhancer binding protein that is similar to C/EBP and heterodimerizes with C/EBP.
    Roman C; Platero JS; Shuman J; Calame K
    Genes Dev; 1990 Aug; 4(8):1404-15. PubMed ID: 2121606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maximal serum stimulation of the c-fos serum response element requires both the serum response factor and a novel binding factor, SRE-binding protein.
    Boulden AM; Sealy LJ
    Mol Cell Biol; 1992 Oct; 12(10):4769-83. PubMed ID: 1328862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between Marek's disease virus encoded or induced factors and the Rous sarcoma virus long terminal repeat promoter.
    Banders UT; Coussens PM
    Virology; 1994 Feb; 199(1):1-10. PubMed ID: 8116231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.